$20 Billion Telemedicine site, GoodRx, is Causing Analysts to Become Cautious

Telemedicine site and prescription-drug pricing app GoodRx Holdings Inc. may draw a wary eye from analysts starting their coverage after the company’s 54% boom to an eye-watering $20 billion valuation.

Source – Why Analysts are questioning GoodRx